Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,951
Closed -$402K 617
2025
Q4
$402K Buy
+2,951
New +$424K 0.1% 262
2025
Q3
Sell
-2,088
Closed -$270K 680
2025
Q2
$270K Buy
+2,088
New +$253K 0.09% 343

Other funds holding XYL

Farringdon Capital's XYL Position: Q1 2026 in Review

Farringdon Capital sold out of Xylem (XYL) in Q1 2026, closing a stake of 2,951 shares — an estimated $402K sold.

Farringdon Capital first reported a position in XYL in Q2 2025 and held it in 2 quarters. The position peaked at $402K in Q4 2025. 1,111 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Farringdon Capital reported no remaining Xylem position as of Q1 2026 after selling out during the quarter.
  • Farringdon Capital sold 2,951 Xylem shares in Q1 2026, an estimated $402K.
  • Farringdon Capital first reported a position in Xylem in Q2 2025 and held it in 2 quarters.
  • Farringdon Capital's Xylem position peaked at $402K in Q4 2025.
  • 1,111 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Farringdon Capital's 13F filing for Q1 2026, filed 15 May 2026.